Prospective evaluation of clarithromycin in recurrent chronic rhinosinusitis with nasal polyps | Zendy

Thiago Freire Pinto Bezerra | Zendy; Rogério Pezato | Zendy; Pâmella Marletti de Barros | Zendy; Larissa Leal Coutinho | Zendy; Leidianny Firmino Costa | Zendy; Fábio Pinna | Zendy; Richard Louis Voegels | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prospective evaluation of clarithromycin in recurrent chronic rhinosinusitis with nasal polyps

Author(s) -

Thiago Freire Pinto Bezerra,

Rogério Pezato,

Pâmella Marletti de Barros,

Larissa Leal Coutinho,

Leidianny Firmino Costa,

Fábio Pinna,

Richard Louis Voegels

Publication year - 2019

Publication title -

brazilian journal of otorhinolaryngology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.488

H-Index - 33

eISSN - 1808-8694

pISSN - 1808-8686

DOI - 10.1016/j.bjorl.2019.09.008

Subject(s) - medicine , clarithromycin , nasal polyps , sinusitis , gastroenterology , interquartile range , prospective cohort study , nose , asthma , population , surgery , helicobacter pylori , environmental health

The antiinflammatory effects of macrolides, especially clarithromycin, have been described in patients with chronic rhinosinusitis without polyps and also other chronic inflammatory airway diseases. There is no consensus in the literature regarding the effectiveness of clarithromycin in patients with chronic rhinosinusitis with sinonasal polyposis and the national literature does not report any prospective studies on the efficacy of clarithromycin in chronic rhinosinusitis in our population.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research